Our study further strengthens the evidence implicating HLA-DQB1 in agranulocytosis and neutropenia, suggesting components of the immune system as contributing to this serious adverse drug reaction. The gene discussed is HLA-DQB1; the disease is Absence of circulating granulocytes.